These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8046974)

  • 1. [Survival--a question of active treatment. High-dose calcium blockers in pulmonary hypertension].
    Husebye ES; Wibell L
    Lakartidningen; 1994 Jun; 91(26-27):2573-5. PubMed ID: 8046974
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.
    Rich S; Kaufmann E; Levy PS
    N Engl J Med; 1992 Jul; 327(2):76-81. PubMed ID: 1603139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful combined therapy of nifedipine and diltiazem for severe hypertension in a maintenance hemodialysis patient.
    Ikeda Y; Sakemi T; Yamada M; Matsumoto J; Yamaguchi K
    Clin Nephrol; 1999 Feb; 51(2):127-8. PubMed ID: 10069650
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially serious drug interactions secondary to high-dose diltiazem used in the treatment of pulmonary hypertension.
    Clarke WR; Horn JR; Kawabori I; Gurtel S
    Pharmacotherapy; 1993; 13(4):402-5. PubMed ID: 8361869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained improvement of pulmonary haemodynamics with low-dose of nifedipine in primary pulmonary hypertension.
    Shimabukuro M; Chibana T; Yoshida H; Nagamine F; Takasu N
    Eur Heart J; 1996 Dec; 17(12):1911-2. PubMed ID: 8960436
    [No Abstract]   [Full Text] [Related]  

  • 7. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The calcium antagonists diltiazem and nifedipine: a comparison of their efficacy in single and long-term use in patients with stable stenocardia of effort].
    Martsevich SIu; Kutishenko PP; Alimova EV; Slastnikova ID; Metelitsa VI
    Ter Arkh; 1998; 70(8):21-5. PubMed ID: 9770738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early pulmonary hypertension: current therapeutic prospectives].
    Pannarale G; Gaspardone A; Acconcia MC; Valente A
    Cardiologia; 1982 Sep; 27(9):883-94. PubMed ID: 6765450
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of calcium channel antagonists in primary pulmonary hypertension in association with human immunodeficiency virus infection].
    Bragulat E; García F; Fernández F; Ballester E; Villalta J; Grau JM
    An Med Interna; 1998 Feb; 15(2):114. PubMed ID: 9542214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of calcium antagonists in the treatment of patients with chronic nonspecific lung diseases].
    Vereshchagina GN; Vasilenko GP; Kuleshova TV
    Klin Med (Mosk); 1988 Mar; 66(3):41-4. PubMed ID: 3392921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative effect of calcium antagonists on hemodynamics in patients with a stable form of essential hypertension (a randomized study)].
    Belousov IuB; Akhadov ShV; Volkov MG
    Ter Arkh; 1994; 66(3):72-7. PubMed ID: 8202859
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes in children with idiopathic pulmonary arterial hypertension.
    Yung D; Widlitz AC; Rosenzweig EB; Kerstein D; Maislin G; Barst RJ
    Circulation; 2004 Aug; 110(6):660-5. PubMed ID: 15289375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing.
    Rich S; Kaufmann E
    J Am Coll Cardiol; 1991 Nov; 18(5):1323-7. PubMed ID: 1918710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New nifedipine preparation makes single daily dose possible].
    Fortschr Med; 1997 Nov; 115(33):following 54. PubMed ID: 9480274
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertensive urgencies: how to give a low dose of short-acting nifedipine.
    Bloomfield RL; Carter J
    Geriatrics; 1996 Sep; 51(9):10. PubMed ID: 8814107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.